Bayer AG
BAYRYOTCHealthcare● Active
$10.20
$-0.10(-0.93%)
Market Cap$40.1B
P/E Ratio—
52W High$14.85
52W Low$7.19
Bayer AG (BAYRY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BAYRY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
$0.79
Est. $0.64 · +23.4%
Revenue
$15.73B
Est. $15.77B · -0.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▲ Beat EPS🔥 5-Quarter EPS Beat Streak
BAYRY reports quarterly as a OTC-listed Drug Manufacturers - General company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.23 | — | — | — | $12.59B | — |
| ▲ Q2 FY2026 | May 12, 2026 | $0.64 | $0.79 | +23.4% | $15.73B | $15.77B | -0.3% |
| — Q1 FY2026 | Mar 4, 2026 | $0.18 | $0.18 | +0.0% | $13.31B | $13.11B | +1.6% |
| ▲ Q4 FY2025 | Nov 12, 2025 | $0.13 | $0.17 | +30.8% | $13.22B | $13.09B | +1.0% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $0.25 | $0.35 | +40.0% | $12.64B | $11.33B | +11.6% |
| — Q1 FY2025 | Mar 5, 2025 | $0.28 | $0.28 | +0.0% | $15.06B | $15.04B | +0.1% |
| — Q4 FY2024 | Dec 31, 2024 | — | -$0.09 | — | $12.15B | — | — |
| ▼ Q4 FY2024 | Nov 12, 2024 | $0.17 | $0.07 | -58.8% | $10.93B | $12.16B | -10.1% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.23
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Beat
EPS Actual
$0.79
EPS Est.
$0.64
EPS Surpr.
+23.4%
Revenue
$15.73B
Q1 FY2026
Mar 4, 2026
EPS Actual
$0.18
EPS Est.
$0.18
EPS Surpr.
+0.0%
Revenue
$13.31B
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
$0.17
EPS Est.
$0.13
EPS Surpr.
+30.8%
Revenue
$13.22B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$0.35
EPS Est.
$0.25
EPS Surpr.
+40.0%
Revenue
$12.64B
Q1 FY2025
Mar 5, 2025
EPS Actual
$0.28
EPS Est.
$0.28
EPS Surpr.
+0.0%
Revenue
$15.06B
Q4 FY2024
Dec 31, 2024
EPS Actual
-$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$12.15B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
$0.07
EPS Est.
$0.17
EPS Surpr.
-58.8%
Revenue
$10.93B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.28 | $0.28 | $0.29 | 1 |
| Q3 FY2027 | $0.20 | $0.20 | $0.20 | 1 |
| Q2 FY2027 | $0.24 | $0.24 | $0.24 | 1 |
| Q1 FY2027 | $0.35 | $0.36 | $0.36 | 1 |
| Q4 FY2026 | $0.05 | $0.05 | $0.05 | 1 |
| Q3 FY2026 | $0.15 | $0.15 | $0.16 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $11.6B | $11.8B | $11.9B | 1 |
| Q3 FY2027 | $9.8B | $9.9B | $10.0B | 2 |
| Q2 FY2027 | $10.8B | $10.9B | $11.0B | 2 |
| Q1 FY2027 | $13.7B | $13.9B | $14.0B | 1 |
| Q4 FY2026 | $11.6B | $11.8B | $11.9B | 2 |
| Q3 FY2026 | $9.9B | $10.0B | $10.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 12, 2026 | +23.4% | $10.88 | $11.21 | +3.03% |
| ▲ Q1 FY2026 | Mar 4, 2026 | +0.0% | $10.97 | $11.05 | +0.73% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +30.8% | $7.92 | $8.37 | +5.68% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +40.0% | $7.96 | $7.25 | -8.92% |
| ▲ Q1 FY2025 | Mar 5, 2025 | +0.0% | $6.20 | $6.60 | +6.45% |
| — Q4 FY2024 | Dec 31, 2024 | — | $4.88 | $4.88 | +0.00% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -58.8% | $6.45 | $5.58 | -13.49% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +0.0% | $7.46 | $7.01 | -6.03% |
Q2 FY2026+3.03%
Report Date
May 12, 2026
EPS Beat/Miss
+23.4%
Price Before
$10.88
Price After
$11.21
Q1 FY2026+0.73%
Report Date
Mar 4, 2026
EPS Beat/Miss
+0.0%
Price Before
$10.97
Price After
$11.05
Q4 FY2025+5.68%
Report Date
Nov 12, 2025
EPS Beat/Miss
+30.8%
Price Before
$7.92
Price After
$8.37
Q3 FY2025-8.92%
Report Date
Aug 6, 2025
EPS Beat/Miss
+40.0%
Price Before
$7.96
Price After
$7.25
Q1 FY2025+6.45%
Report Date
Mar 5, 2025
EPS Beat/Miss
+0.0%
Price Before
$6.20
Price After
$6.60
Q4 FY2024+0.00%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$4.88
Price After
$4.88
Q4 FY2024-13.49%
Report Date
Nov 12, 2024
EPS Beat/Miss
-58.8%
Price Before
$6.45
Price After
$5.58
Q3 FY2024-6.03%
Report Date
Aug 6, 2024
EPS Beat/Miss
+0.0%
Price Before
$7.46
Price After
$7.01
Avg Beat Reaction+0.16%
Avg Miss Reaction-13.49%
Beat Rate6 / 8 quarters
Largest Move-13.49% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BAYRY ends December
Bayer AG (BAYRY) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $0.79 — beating the analyst consensus of $0.64 by +23.4%. BAYRY has beaten EPS estimates for 5 consecutive quarters. The next BAYRY earnings date is expected around September 1, 2026.
Each quarter, investors track BAYRY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BAYRY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BAYRY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BAYRY earnings · 5 questionsBayer AG's next earnings report is expected around September 1, 2026. BAYRY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BAYRY historically reports after market close (AMC).
BAYRY earnings datewhen is BAYRY earningsBAYRY next earnings datewhen does BAYRY report earningsBAYRY earnings calendar
▸ Source: FMP · Bayer AG SEC filings · US GAAP · Bayer AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026